Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California.

Urogenital Neisseria gonorrhoeae isolates (266) collected in San Francisco, CA, in 2009 were analyzed for antimicrobial susceptibility and were subsequently genotyped by N. gonorrhoeae multiantigen sequence typing (NG-MAST). Isolates of identical or closely related sequence types were found to possess highly similar phenotypes with regard to drug susceptibility. Isolates containing decreased susceptibility to oral cephalosporins were detected in 2009 and were found to contain the mosaic penA allele (XXXIV) found previously to be associated with decreased susceptibility to cephalosporins. A better understanding of the relationships between phenotypic and genotypic markers for antimicrobial resistance may be helpful to the development of effective surveillance systems for drug-resistant N. gonorrhoeae.

[1]  P. Bloomfield.  Update on emerging infections: news from the Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. , 2007, Annals of emergency medicine.

[2]  Takashi Ida,et al.  Amino Acid Substitutions in Mosaic Penicillin-Binding Protein 2 Associated with Reduced Susceptibility to Cefixime in Clinical Isolates of Neisseria gonorrhoeae , 2006, Antimicrobial Agents and Chemotherapy.

[3]  J. Felsenstein.  Evolutionary trees from DNA sequences: A maximum likelihood approach , 2005, Journal of Molecular Evolution.

[4]  Jeffrey D. Klausner,et al.  Mosaic Penicillin-Binding Protein 2 in Neisseria gonorrhoeae Isolates Collected in 2008 in San Francisco, California , 2009, Antimicrobial Agents and Chemotherapy.

[5]  M. Yasuda,et al.  Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  H. Palmer,et al.  Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing , 2008, Sexually Transmitted Infections.

[7]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[8]  R. Kirkcaldy,et al.  Gonococcal Resistance: Are Cephalosporins Next? , 2011, Current infectious disease reports.

[9]  M. Pandori,et al.  Clinical Neisseria gonorrhoeae isolates in the United States with resistance to azithromycin possess mutations in all 23S rRNA alleles and the mtrR coding region. , 2011, Microbial drug resistance.

[10]  M. Yasuda,et al.  Rapid Detection of the Mosaic Structure of the Neisseria gonorrhoeae penA Gene, Which Is Associated with Decreased Susceptibilities to Oral Cephalosporins , 2008, Journal of Clinical Microbiology.

[11]  M. Unemo,et al.  Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone , 2011, Antimicrobial Agents and Chemotherapy.

[12]  Vanessa G. Allen,et al.  Molecular Analysis of Antimicrobial Resistance Mechanisms in Neisseria gonorrhoeae Isolates from Ontario, Canada , 2010, Antimicrobial Agents and Chemotherapy.

[13]  M. Unemo,et al.  Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae , 2009, Expert review of anti-infective therapy.

[14]  Kevin A Fenton,et al.  Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. , 2004, The Journal of infectious diseases.

[15]  J. Cannon,et al.  Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes , 1991, Journal of bacteriology.

[16]  P. Barry,et al.  The use of cephalosporins for gonorrhea: the impending problem of resistance , 2009 .

[17]  M. Unemo,et al.  Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  M. Yasuda,et al.  Threat to Cefixime Treatment for Gonorrhea , 2007, Emerging infectious diseases.